Synergy Pharmaceuticals, Bristol-Myers deal

Synergy acquired FV-100 from Bristol-Myers Squibb six months after the pharma gained the shingles product through its $2.5 billion takeover of Inhibitex Inc. in February. Bristol-Myers will receive ...